title: Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).
abstract: OBJECTIVE
  The Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) was a multicenter randomized prospective study of 153 male type 2 diabetic patients to assess the ability to sustain clinically significant glycemic separation between intensive and standard treatment arms. A trend toward an excess of combined cardiovascular events in the intensive treatment arm of this trial was reported earlier. The present analysis was done to evaluate the effect of 2 years of intensive glycemic control on the left ventricular (LV) function.
  
  
  METHODS
  The patients were randomized to intensive step treatment with insulin alone or with sulfonylurea (intensive treatment arm [INT], n = 75) or to standard once-daily insulin injection (standard treatment arm [STD], n = 78) treatment. A total of 136 patients (standard treatment arm [STD], n = 70; INT, n = 66) had radionuclide ventriculography at entry and at 24 months for the assessment of LV function.
  
  
  RESULTS
  There was no difference in the mean LV ejection fraction (at entry: STD 57.1+/-9.51%; INT 58.1+/-8.7%; at 24 months: STD 57.3+/-10.8%, INT 59.5+/-10.7%), peak filling rate (at entry: STD 2.6+/-0.7 end diastolic volume per second, INT 2.4+/-0.8 end diastolic volume per second; at 24 months: STD 2.7+/-1.0 end diastolic volume per second, INT 2.5+/-0.7 end diastolic volume per second), or time to peak filling rate (at entry: STD 195.3+/-69.5 ms, INT 185.6 +/-62.4 ms; at 24 months: STD 182.6+/-64.8 ms, INT 179.2+/-61.2 ms) between the 2 treatment arms. A subgroup analysis of 104 patients (STD, n = 53; INT, n = 51) that omitted individuals with intervening cardiac events/revascularization or a change in cardioactive medications also showed no difference in the LV function at entry and at 24 months between the 2 groups. Abnormal LV ejection fraction at baseline predicted cardiac events (interval between cardiac beats [RR] = 2.5).
  
  
  CONCLUSIONS
  Two years of intensive glycemic control does not affect the LV systolic or diastolic function in patients with type 2 diabetes.
authors.affiliation: Endocrinology and Diabetes Division, Hines VA Hospital, Illinois, USA.
authors.forename: S U
authors.initials: SU
authors.lastname: Pitale
authors.forename: C
authors.initials: C
authors.lastname: Abraira
authors.forename: N V
authors.initials: NV
authors.lastname: Emanuele
authors.forename: M
authors.initials: M
authors.lastname: McCarren
authors.forename: W G
authors.initials: WG
authors.lastname: Henderson
authors.forename: I
authors.initials: I
authors.lastname: Pacold
authors.forename: D
authors.initials: D
authors.lastname: Bushnell
authors.forename: J A
authors.initials: JA
authors.lastname: Colwell
authors.forename: F Q
authors.initials: FQ
authors.lastname: Nuttall
authors.forename: S R
authors.initials: SR
authors.lastname: Levin
authors.forename: C T
authors.initials: CT
authors.lastname: Sawin
authors.forename: J P
authors.initials: JP
authors.lastname: Comstock
authors.forename: C K
authors.initials: CK
authors.lastname: Silbert
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D015635:Radionuclide Ventriculography; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D013997:Time Factors; D016277:Ventricular Function, Left
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds